Programme

Draft Talk Topics

Day 1 Wednesday 16 May

Morning:

The Diabetic Foot in 2018

  • The ever increasing impact of diabetic foot disease on health economics.
  • In-patient Diabetes Footcare: an update
  • Can a good diabetic foot service reduce amputations?
  • Disparities in lower limb vascular services across the UK – can we improve?

Afternoon:

Can we do better?

  • Lessons from “Europe!”: the Maastricht and Eurodiale Studies
  • Lessons from Scotland – how to optimise diabetic foot services
  • Creating a five star diabetic foot clinic

Day 2 Thursday 17 May

Morning:

Assessment of the diabetic foot

  • How to critically assess published diabetic foot studies
  • Interpreting the plain foot x-ray:  pearls from a true expert
  • Psyching out the diabetic foot
  • Technology and the diabetic foot in 2018

What evidence is there for interventions?

  • Use of dressings in diabetic foot ulcer care:  is there any evidence?
  • What’s new from the gait laboratory and can exercise training help unsteadiness?
  • An update on antibiotic therapy for diabetic foot infections

Afternoon:

Oral presentations of submitted and accepted abstracts and joint symposium with the British Orthopaedic Foot and Ankle Society

 

Day 3 Friday 18 May

Morning:

Medical management of foot ulceration

  • The development of Manuka honey for advanced wound care – where is the evidence?
  • Common mistakes in diabetic foot management
  • Challenges in treating neuro ischaemic diabetic foot ulcers:  current standard of care and beyond
  • Medical management of osteomyelitis

Surgical aspects of diabetic foot care

  • Antibiotics vs surgery for osteomyelitis – any difference?
  • Differentiation of osteomyelitis from acute Charcot neuroarthropathy – which investigation?
  • Does medical management have any place in the management of acute Charcot neuropathy?
  • Surgical management of Charcot neuroarthropathy
  • Vascular and endovascular procedures in the diabetic lower limb

This meeting is supported by grants and sponsorship from the pharmaceutical and device industries.
See here for details.